Be part of the knowledge - Global Oncology Academy

Medical News

news.illinois.edu
09/23/2022
Medical News
DNA Nets Capture COVID-19 Virus in Low-Cost Rapid-Testing Platform
Read more
medicalxpress.com
09/23/2022
Medical News
Study Pinpoints Origin of Pediatric Brain Tumor Type & Shows It May Be Preventa…
Read more
prnewswire.com
09/23/2022
Medical News
NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bival…
Read more
news.ucr.edu
09/23/2022
Medical News
Robot Sleeves for Kids with Cerebral Palsy
Read more

See more news

- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
0
CME/CE
Multiple Myeloma: Updates from ASCO 2022
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
- Monique Hartley-Brown, MD, MMSc
  Peer
- Shonali Midha, MD
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
0.25 credits
- Ian W. Flinn, MD, PhD
  Peer
- William Wierda, MD
  Peer
1
CME/CE
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
0.25 credits
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling…
0.25 credits
- Jacob D. Soumerai, MD
  Peer
- Andrew H. Lipsky, MD
  Peer
2
CME/CE
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
0.25 credits
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
0.25 credits
- Cesar Rodriquez Valdes, MD
  Peer
- Amrita Krishnan, MD
  Peer
4
CME/CE
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits
- Susan O’Brien, MD
  Peer
- Timothy Call, MD
  Peer
1
CME/CE
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
- Caitlin Costello, MD
  Peer
1
Oncology and Hematology
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
- Jacob Sands, MD
  Peer
- Maya Leiva, PharmD, BCOP
  Peer
0
Project Oncology®
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients

CME/CE

- Amrita Krishnan, MD
  Peer
- Morie Gertz, MD, MACP
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Rel…
0.25 credits
- Elizabeth Smyth, MD
  Peer
- Jaffer Ajani, MD
  Peer
4
CME/CE
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
0.25 credits
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GE…
0.25 credits
- Amer Zeidan, MBBS
  Peer
- Amy E. DeZern, MD, MHS
  Peer
5
CME/CE
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
0.25 credits
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
0.25 credits
- Jacqueline Garcia, MD
  Peer
- David A. Sallman, MD
  Peer
3
CME/CE
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
0.25 credits
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Str…
0.25 credits

Clinical Practice

- Pavani Chalasani MD, MPH
  Peer
- Nan Chen, MD
  Peer
0
Project Oncology®
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
- Pavani Chalasani MD, MPH
  Peer
- Seema A. Khan, MD
  Peer
0
Project Oncology®
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
- Jacob Sands, MD
  Peer
- Maya Leiva, PharmD, BCOP
  Peer
0
Project Oncology®
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
- Sagar Lonial, MD, FACP
  Peer
- Noopur Raje, MD
  Peer
3
CME/CE
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
0.25 credits
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
0.25 credits

Programs

- Pavani Chalasani MD, MPH
  Peer
- Erika Hamilton, MD
  Peer
0
Project Oncology®
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
0.25 credits
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
0.25 credits
- Pavani Chalasani MD, MPH
  Peer
- Kevin Kalinsky MD, MS
  Peer
0
Project Oncology®
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Conversations Around Chemotherapy: Do All of Your Patients Need It?
- Andrew M. Brunner, MD
  Peer
- Amy E. DeZern, MD, MHS
  Peer
5
CME/CE
A New Light in Higher-Risk MDS: Emerging Treatment Options
A New Light in Higher-Risk MDS: Emerging Treatment Options
0.25 credits
A New Light in Higher-Risk MDS: Emerging Treatment Options
0.25 credits

Medical News

Medical News

Medical News

Medical News

Medical News

Popular

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Oncology and Hematology

Project Oncology®

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Clinical Practice

Project Oncology®

Project Oncology®

Project Oncology®

CME/CE

Programs

Project Oncology®

CME/CE

Project Oncology®

CME/CE

NEED HELP?

Contact us

NEED HELP?

Contact us

Medical News

Medical News

Medical News

Medical News

Medical News

Popular

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Oncology and Hematology

Project Oncology®

CME/CE

CME/CE

CME/CE

CME/CE

CME/CE

Clinical Practice

Project Oncology®

Project Oncology®

Project Oncology®

CME/CE

Programs

Project Oncology®

CME/CE

Project Oncology®

CME/CE

Title

Share on ReachMD

Get a Dose of Global Oncology Academy in Your Inbox and Practice Smarter Medicine

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.